4.5 Article

Physical Fitness Training in Patients with Subacute Stroke (PHYS-STROKE): multicentre, randomised controlled, endpoint blinded trial

期刊

BMJ-BRITISH MEDICAL JOURNAL
卷 366, 期 -, 页码 -

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/bmj.l5101

关键词

-

资金

  1. German Ministry for Health and Education through Center for Stroke Research Berlin grant [01EO0801, G.2.15]

向作者/读者索取更多资源

OBJECTIVE To determine the safety and efficacy of aerobic exercise on activities of daily living in the subacute phase after stroke. DESIGN Multicentre, randomised controlled, endpoint blinded trial. SETTING Seven inpatient rehabilitation sites in Germany (2013-17). PARTICIPANTS 200 adults with subacute stroke (days 5-45 after stroke) with a median National Institutes of Health stroke scale (NIHSS, range 0-42 points, higher values indicating more severe strokes) score of 8 (interquartile range 5-12) were randomly assigned (1: 1) to aerobic physical fitness training (n=105) or relaxation sessions (n=95, control group) in addition to standard care. INTERVENTION Participants received either aerobic, bodyweight supported, treadmill based physical fitness training or relaxation sessions, each for 25 minutes, five times weekly for four weeks, in addition to standard rehabilitation therapy. Investigators and endpoint assessors were masked to treatment assignment. MAIN OUTCOME MEASURES The primary outcomes were change in maximal walking speed (m/s) in the 10 m walking test and change in Barthel index scores (range 0-100 points, higher scores indicating less disability) three months after stroke compared with baseline. Safety outcomes were recurrent cardiovascular events, including stroke, hospital readmissions, and death within three months after stroke. Efficacy was tested with analysis of covariance for each primary outcome in the full analysis set. Multiple imputation was used to account for missing values. RESULTS Compared with relaxation, aerobic physical fitness training did not result in a significantly higher mean change in maximal walking speed (adjusted treatment effect 0.1 m/s (95% confidence interval 0.0 to 0.2 m/s), P=0.23) or mean change in Barthel index score (0 (-5 to 5), P=0.99) at three months after stroke. A higher rate of serious adverse events was observed in the aerobic group compared with relaxation group (incidence rate ratio 1.81, 95% confidence interval 0.97 to 3.36). CONCLUSIONS Among moderately to severely affected adults with subacute stroke, aerobic bodyweight supported, treadmill based physical fitness training was not superior to relaxation sessions for maximal walking speed and Barthel index score but did suggest higher rates of adverse events. These results do not appear to support the use of aerobic bodyweight supported fitness training in people with subacute stroke to improve activities of daily living or maximal walking speed and should be considered in future guidelines.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Elevation of cardiac biomarkers in stroke is associated with pathological findings on cardiac MRI-results of the HEart and BRain interfaces in Acute Stroke study

Regina von Rennenberg, Juliane Herm, Thomas Krause, Simon Hellwig, Helena Stengl, Jan F. Scheitz, Thomas Elgeti, Sebastian N. Nagel, Matthias Endres, Karl Georg Haeusler, Christian H. Nolte

Summary: This study found that elevated cardiac biomarkers, such as high-sensitivity cardiac troponin T (hs-cTnT) and brain natriuretic peptide (BNP), in acute stroke patients are strongly associated with pathological findings on cardiac magnetic resonance imaging (CMR). The elevation of these biomarkers may help identify patients who require a more comprehensive cardiology work-up.

INTERNATIONAL JOURNAL OF STROKE (2023)

Article Clinical Neurology

Cerebral small vessel disease burden and cognitive and functional outcomes after stroke: A multicenter prospective cohort study

Marios K. Georgakis, Rong Fang, Marco Duering, Frank A. Wollenweber, Felix J. Bode, Sebastian Stoesser, Christine Kindlein, Peter Hermann, Thomas G. Liman, Christian H. Nolte, Lucia Kerti, Benno Ikenberg, Kathleen Bernkopf, Holger Poppert, Wenzel Glanz, Valentina Perosa, Daniel Janowitz, Michael Wagner, Katja Neumann, Oliver Speck, Laura Dobisch, Emrah Duezel, Benno Gesierich, Anna Dewenter, Annika Spottke, Karin Waegemann, Michael Goertler, Silke Wunderlich, Matthias Endres, Inga Zerr, Gabor Petzold, Martin Dichgans

Summary: The global burden of small vessel disease (SVD) predicts cognitive and functional outcomes in stroke patients, but the current score used for assessment does not improve prediction capability. Assessing the severity of SVD lesions adds value in predicting outcomes beyond known predictors.

ALZHEIMERS & DEMENTIA (2023)

Letter Allergy

Prospective (e-diary) vs retrospective ( ARIA) measures of severity in allergic rhinoconjunctivitis: An observational compatibility study

Stephanie Dramburg, Serena Perna, Marco Di Fraia, Salvatore Tripodi, Stefania Arasi, Sveva Castelli, Danilo Villalta, Francesca Buzzulini, Ifigenia Sfika, Valeria Villella, Ekaterina Potapova, Maria Antonia Brighetti, Alessandro Travaglini, Simone Pelosi, Ulrike Grittner, Paolo Maria Matricardi

ALLERGY (2023)

Article Clinical Neurology

Effect of Mobile Stroke Unit Dispatch in all Patients with Acute Stroke or TIA

Jessica L. L. Rohmann, Marco Piccininni, Martin Ebinger, Matthias Wendt, Joachim E. E. Weber, Eugen Schwabauer, Frederik Geisler, Erik Freitag, Peter Harmel, Irina Lorenz-Meyer, Ira Rohrpasser-Napierkowski, Christian H. H. Nolte, Darius G. G. Nabavi, Ingo Schmehl, Axel Ekkernkamp, Matthias Endres, Heinrich J. J. Audebert

Summary: This study used data from the B_PROUD study in Berlin to examine the effect of additional mobile stroke unit (MSU) dispatch on functional outcomes among all stroke patients. The results showed that MSU dispatch was associated with improved 3-month functional outcomes, without any significant association with the primary disability scale or 7-day mortality.

ANNALS OF NEUROLOGY (2023)

Review Clinical Neurology

Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal

Andreas Meisel, Fulvio Baggi, Anthony Behin, Amelia Evoli, Anna Kostera-Pruszczyk, Renato Mantegazza, Raul Juntas Morales, Anna Rostedt Punga, Sabrina Sacconi, Michael Schroeter, Jan Verschuuren, Louise Crathorne, Kris Holmes, Maria-Isabel Leite

Summary: This study examined the relationship between autoantibody levels and disease activity in patients with myasthenia gravis (MG). The results indicated a potential positive correlation, which could have clinical implications in guiding treatment decisions. However, due to limited and variable evidence, routine clinical use of autoantibody level testing is not currently recommended.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Article Clinical Neurology

Autoantibody detection by a live cell-based assay in conventionally antibody-tested triple seronegative Myasthenia gravis

Sarah Hoffmann, Patrick Waters, Leslie Jacobson, Markus Schuelke, Werner Stenzel, Tobias Ruck, Sophie Lehnerer, Frauke Stascheit, Corinna Preusse, Andreas Meisel

Summary: Autoantibody testing is essential for autoimmune myasthenia gravis diagnosis, but about 15% of patients still show negative results (seronegative MG). This study examined the prevalence of clustered AChR, MuSK, and LRP4 autoantibodies in a large German cohort of seronegative MG patients using a live cell-based assay. Out of 67 SNMG patients, 4.5% had clustered AChR autoantibodies, with two patients showing binding to both adult and fetal AChR. None of the patients tested positive for MuSK or LRP4 autoantibodies. Clinical characteristics were similar between patients with and without clustered AChR autoantibodies. Comparisons with a national MG registry showed broad similarities among seronegative MG patients in both cohorts.

NEUROMUSCULAR DISORDERS (2023)

Article Medicine, General & Internal

Patient-reported burden of myasthenia gravis: baseline results of the international prospective, observational, longitudinal real-world digital study MyRealWorld-MG

Sarah Dewilde, Glenn Philips, Sandra Paci, Jon Beauchamp, Silvia Chiroli, Casey Quinn, Laura Day, Mark Larkin, Jacqueline Palace, Sonia Berrih-Aknin, Kristl G. Claeys, Srikanth Muppidi, Renato Mantegazza, Francesco Sacca, Andreas Meisel, Guillaume Bassez, Hiroyuki Murai, M. F. Janssen

Summary: This study aims to explore the impact of myasthenia gravis (MG) on health-related quality of life (HRQoL) from the perspective of patients. The results showed that MG significantly affects patients' daily activities, anxiety and depression, fatigue, breathing, and vision. The impact of the disease becomes more severe with increasing disease severity.

BMJ OPEN (2023)

Article Clinical Neurology

Serum neurofilament light chain in myasthenia gravis subgroups: An exploratory cohort and case-Control study

Frauke Stascheit, Annette Aigner, Philipp Mergenthaler, Benjamin Hotter, Sarah Hoffmann, Sophie Lehnerer, Christian Meisel, Andreas Meisel

Summary: This study aimed to evaluate the association between Nfl and neuromuscular destruction and disease severity in MG patients. Serum samples from MG patients and controls were analyzed and compared. The results showed that sNfl levels were higher in MG patients compared to controls, but were not consistently associated with disease severity. Thus, sNfl is not a suitable biomarker for monitoring individual disease progression in MG patients.

FRONTIERS IN NEUROLOGY (2023)

Article Immunology

Association of cerebrospinal fluid brain-binding autoantibodies with cognitive impairment in post-COVID-19 syndrome

Christiana Franke, Fabian Boesl, Yasemin Goereci, Ameli Gerhard, Finja Schweitzer, Maria Schroeder, Helle Foverskov-Rasmussen, Josephine Heine, Anneke Quitschau, Farid I. Kandil, Ann-Katrin Schild, Carsten Finke, Heinrich J. Audebert, Matthias Endres, Clemens Warnke, Harald Pruess

Summary: Autoantibodies targeting brain epitopes are common in patients with post-COVID-19 syndrome (PCS) and strongly associate with pathological cognitive screening tests, particularly when found in cerebrospinal fluid (CSF).

BRAIN BEHAVIOR AND IMMUNITY (2023)

Article Medicine, General & Internal

Patient-reported impact of myasthenia gravis in the real world: findings from a digital observational survey-based study (MyRealWorld MG)

Sonia Berrih-Aknin, Jacqueline Palace, Andreas Meisel, Kristl G. Claeys, Srikanth Muppidi, Francesco Sacca, Fatemeh Amini, Mark Larkin, Casey Quinn, Jon Beauchamp, Glenn Philips, Femke De Ruyck, Joyce Ramirez, Sandra Paci

Summary: This study aims to explore the impact of myasthenia gravis (MG) in the real world from a patient perspective. The study included MG patients from different countries and found that despite current treatments, patients still experience a significant burden.

BMJ OPEN (2023)

Article Medicine, Research & Experimental

Eculizumab treatment alters the proteometabolome beyond the inhibition of complement

Christopher Nelke, Christina B. Schroeter, Frauke Stascheit, Niklas Huntemann, Marc Pawlitzki, Alice Willison, Saskia Raeuber, Nico Melzer, Ute Distler, Stefan Tenzer, Kai Stuehler, Andreas Roos, Andreas Meisel, Sven G. Meuth, Tobias Ruck

Summary: Therapeutic strategies targeting complement have revolutionized the treatment of myasthenia gravis. A combined proteomics and metabolomics approach was used to study a cohort of MG patients treated with eculizumab or azathioprine, as well as treatment-naive patients. Eculizumab was found to modulate the serum proteometabolome, affecting pathways related to oxidative stress, MAP kinase signaling, and lipid metabolism, particularly arachidonic acid signaling.

JCI INSIGHT (2023)

Article Clinical Neurology

Extent of routine diagnostic cardiac work-up at certified German stroke units participating in the prospective MonDAFIS study

Manuel C. Olma, Serdar Tuetuencue, Ulrike Grittner, Claudia Kunze, Muhammad Jawad-Ul-Qamar, Paulus Kirchhof, Joachim Roether, Goetz Thomalla, Roland Veltkamp, Ulrich Laufs, Darius G. Nabavi, Peter U. Heuschmann, Matthias Endres, Karl Georg Haeusler

Summary: Little is known about the extent and standardization of routine cardiac diagnostic work-up at certified stroke-units in Germany. This study analyzed the routine diagnostic work-up at different stroke centres in Germany and found that detection of atrial fibrillation (AF) varied among the centres, with lower detection rates in university-based comprehensive stroke centres compared to non-university-based and primary stroke centres. The use of echocardiography and Holter-ECG monitoring also differed among the centres.

NEUROLOGICAL RESEARCH AND PRACTICE (2023)

Article Neuroimaging

7T amygdala and hippocampus subfields in volumetry-based associations with memory: A 3-year follow-up study of early Alzheimer's disease

Laura Goeschel, Lea Kurz, Andrea Dell'Orco, Theresa Koebe, Peter Koertvelyessy, Ariane Fillmer, Semiha Aydin, Layla Tabea Riemann, Hui Wang, Bernd Ittermann, Ulrike Grittner, Agnes Floeel

Summary: This study compared the contribution of hippocampal and amygdalar volumes in the diagnosis and prediction of Alzheimer's disease (AD). The results showed that measurements of amygdalar volumes might help identify patients with subjective cognitive decline (SCD), but its association with other psychiatric disorders needs further evaluation. In patients with mild cognitive impairment (MCI), memory decline over 3 years was more strongly associated with hippocampal volumes than amygdalar volumes.

NEUROIMAGE-CLINICAL (2023)

Article Neuroimaging

Comparison of anatomical-based vs. nTMS-based risk stratification model for predicting postoperative motor outcome and extent of resection in brain tumor surgery

Meltem Ivren, Ulrike Grittner, Rutvik Khakhar, Francesco Belotti, Heike Schneider, Paul Poeser, Federico D'Agata, Giannantonio Spena, Peter Vajkoczy, Thomas Picht, Tizian Rosenstock

Summary: This study compared two statistical models, one based on clinicoradiological prognostic sum score and the other based on navigated transcranial magnetic stimulation and diffusion-tensor-imaging tractography, for predicting postoperative motor outcome in glioma patients. The results showed that the model based on navigated transcranial magnetic stimulation and diffusion-tensor-imaging tractography was superior to the clinicoradiological prognostic sum score model, and a combined model combining both models was more accurate in predicting the extent of resection. Therefore, functional data from navigated transcranial magnetic stimulation combined with tractography should be used for patient counseling and surgical planning in patients with motor-associated tumors.

NEUROIMAGE-CLINICAL (2023)

暂无数据